Doxorubicin is an anthracycline type antineoplastic agent which may show significant cardiotoxic effects.
  Doxorubicin toxicity does not have a specific ECG sign. Many ECG abnormalities observed in heart failure patients may also be observed during Doxorubicin-induced cardiomyopathy.
  Doxorubicin-induced cardiomyopathy may even appear years after the administration of this agent.
ECG abnormalities that may be observed during Doxorubicin-induced cardiomyopathy
ECG 1. The ECG above is from a 57 years-old woman who had received Doxorubicin therapy for breast cancer 17 years ago.
Now, she has normal coronary arteries but severe left ventricular systolic dysfunction (with an ejection fraction of 20%).
The basic rhythm is sinus tachycardia accompanied by frequent end-diastolic VPCs.
Completely negative P waves in lead V1 denote left atrial abnormality.
Low voltage is seen in the limb leads.
The ECG above has been used with the permission of Texas Heart Institute Journal.